Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Cancer Chemotherapy and Pharmacology|December 8, 2025
Lack of effects of S-equol-containing supplement on the pharmacokinetics of oral hormone therapy drugs for breast cancerTakehiko Sambe, Chiyo K Imamura, Noriko Hida, et al.Gerontology|June 24, 2025
Identification of a Risk Allele at SLC41A3 and a Protective Allele HLA-DPB1*02:01 Associated with Sarcopenia in JapaneseMotoki Furutani, Tetsuaki Kimura, Koya Fukunaga, et al.Pharmacogenetics and Genomics|February 22, 2022
Accuracy and applications of sequencing and genotyping approaches for CYP2A6 and homologous genesAlec W R Langlois, Ahmed El-Boraie, Koya Fukunaga, et al.Journal of Human Genetics|April 14, 2023
Genotyping, characterization, and imputation of known and novel CYP2A6 structural variants using SNP array dataAlec W R Langlois, Ahmed El-Boraie, Jennie G Pouget, et al.Biochemical Pharmacology|February 12, 2026
Genetic variants of flavin-containing monooxygenase (FMO) 1 and FMO3 in 5887 dogs influenced oxygenations of probe substrates benzydamine, trimethylamine, and methyl p-tolyl sulfideYasuhiro Uno, Koya Fukunaga, Makiko Shimizu, et al.Biochemical Pharmacology|October 5, 2025
Genetic variants of cytochrome P450 2C21 identified by screening 6344 dogs influenced oxidations of the probe drug omeprazoleYasuhiro Uno, Koya Fukunaga, Genki Ushirozako, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 13, 2025
Genetic variants in dog cytochrome P450 2B6 and their relevance to interindividual variability of oxidations of probe drug propofolYasuhiro Uno, Koya Fukunaga, Genki Ushirozako, et al.Pharmacological Research|January 16, 2022
Identification and functional validation of novel pharmacogenomic variants using a next-generation sequencing-based approach for clinical pharmacogenomicsStavroula Siamoglou, Maria Koromina, Eiji Hishinuma, et al.Clinical Pharmacology and Therapeutics|December 10, 2020
Transferability of Ancestry-Specific and Cross-Ancestry CYP2A6 Activity Genetic Risk Scores in African and European PopulationsAhmed El-Boraie, Meghan J Chenoweth, Jennie G Pouget, et al.Immunohorizons|January 13, 2023
Augmenting Granzyme B-Expressing NK Cells by Invariant NKT Ligand-Loaded APCs in Patients with Postoperative Early Stage Non-Small Cell Lung Cancer: Results of a Randomized Phase II StudyTomonori Iyoda, Kanako Shimizu, Masami Kawamura, et al.Pageof 4